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Abstract 
This paper investigates the relation between viral infection and cell uptake of liposomes and nanoparticles. A defective virus was used 
to infect two types of cells: cells allowing virus budding (psi2neo cells) and cells bereft of a virus exit process (NIH 3T3 cells). This 
study has revealed that cell uptake of pH-sensitive-liposomes is highly dependent on the virus exit process, since it ensued only when 
virus budding occurred. This preferential uptake of pH-sensitive liposomes by infected cells was not carrier-specific because similar 
uptake was observed with non-biodegradable f uorescent nanoparticles using confocal microscopy. Also, inhibition of neo gene 
expression by oligonucleotide pH-sensitive-liposomes was only observed in the cell system (psi2neo) endowed with a virus exit process. 
Finally, increased membrane fluidity was noted in the infected cells, possibly reflecting membrane perturbation due to virus budding. We 
suggest hat this membrane perturbation may be the key to the uptake of the different colloidal carriers. Infected cells could, thus, 
constitute a natural target for particulate drug carriers. 
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1. Introduction 
Since the discovery of the agent responsible for AIDS 
and the devastating effects of this virus, new antiretroviral 
therapies are urgently needed. Oligonucleotides are poten- 
tial antiviral molecules capable of controlling viral gene or 
oncogene xpression (see review, Hrl~ne and Toulmr) [1]. 
They have been used successfully in cell culture to inhibit 
the expression of specific HIV genes [2-4] and there is 
now widespread interest irt extending the use of antisense 
compounds to the in vivo setting [5,6]. Many chemical 
modifications have been proposed to solve the problem of 
the enzymatic degradation of the oligonucleotides ( ee 
review, Goodchild) [7]. 'Drug carder systems' such as 
nanoparticles [8] and liposomes [9-11] have been used to 
enhance the cellular uptake of these compounds, of the 
duration of their activity and to target them more effi- 
ciently. A major drawback of carrier systems in treatment 
strategies is that they are not cell-specific. Liposomes, 
however, can be coupled to various ligands, such as mono- 
clonal antibodies, which then permit their targeting of 
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specific cell populations [9,12]. But the efficiency of this 
process is dependent on the nature of the targeted surface 
molecules and on the size of the liposome used [13,14]. 
Recently, oligonucleotides directed against he env mRNA 
of the murine Friend retrovirus were encapsulated in pH- 
sensitive liposomes and an antisense activity was noted 
with this type of carrier [15]. These liposomes are stable at 
physiological pH, but after being internalized by cells via 
an endocytic pathway, liposomes exposed to the acidic pH 
of the endosome are destabilized and possibly fuse with 
the endosome membrane. This results in the release of 
their contents into the cytoplasm without degradation by 
lysosomal enzymes. A slight difference of the activity has 
been observed between oligonucleotides encapsulated in
pH-sensitive liposomes and non-pH-sensitive liposomes 
[16]. This finding prompted us to investigate interactions 
between cells and liposomes. 
This paper is an attempt o identify the mechanism 
governing uptake of liposomes by infected cells. Two 
types of investigations have been performed. We first tried 
to determine the relationship between cellular uptake and 
activity of oligonucleotide liposomes and retrovirus bud- 
ding. Secondly, using polystyrene nanoparticles (with 
roughly the same size as liposomes), we compared uptake 
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by infected and non-infected cells. The present study 
shows, for the first time, that in vitro cell uptake of 
colloidal carriers (liposomes or polystyrene nanoparticles), 
whatever their composition, is directly dependent on the 
process whereby the retrovirus exits from murine fibrob- 
lasts. This observation could stimulate new strategies in 
the treatment of retroviral infections. 
2. Materials and methods 
2.1. Oligonucleotide synthesis 
The oligonucleotide target was the neo gene present in 
psi2neo cells and in transfected NIH 3T3 cells. The 
antisense complementary to the 5' region of the initiation 
codon AUG of the neo gene was synthesized on an 
automated DNA synthesizer (model 380 B, Applied 
Biosystems, Foster City, CA, USA). The sequence was 
5'GCGTACTAACTTGTT3'. The control oligomer had the 
fo l lowing reverse antisense compos i t ion:  5' 
TTGTTCAATCATGCG3'. The oligonucleotides were pu- 
rified by ethanol precipitation and centrifugation. The 5' 
end of the oligonucleotides was labeled with 32p using T4 
polynucleotide kinase at 37°C for 30 min. The quality of 
oligonucleotide purification was then evaluated through 
electrophoresis (20% polyacrylamide 7 M urea gel). 
2.2. Preparation of liposomes 
Liposomes were prepared by reverse phase 
evaporation[15]. Briefly: the organic phase was constituted 
by ethanol/chloroform at a ratio of 1:1 in which phospho- 
lipids (phosphatidylethanolamine/acide oleic/cholesterol 
at a ratio of 10:5:2) were dissolved. The aqueous phase 
was composed of oligonucleotides at 600 /xg/ml in a 
buffer (Tris EDTA, pH = 7.8). Non-encapsulated oligo- 
nucleotides were separated from liposomes by Sepharose 
4B gel filtration. The liposomes were labelled with 14C 
dioleylphosphatidylethanolamine (Am rsham) and the ac- 
tivity used in the final preparation was 0.02 /xCi//xmol of 
phospholipids. 
2.3. Preparation of fluorescent polystyrene nanoparticles 
Polystyrene nanoparticles were prepared using the 
method reported by Fessi et al. [17], which was slightly 
modified. Briefly, 10 mg of Polystyrene (Estapor ®, Pro- 
labo, France) and 5 mg of phospholipids (Epikuron ® 170, 
Lucas Meyer) were dissolved in 10 ml of acetone; the 
solution was mixed, under magnetic stirring, with an aque- 
ous phase (20 ml) containing 5 mg of Poloxamer ~(ICI). 
After 10 min of stirring, acetone and water were evapo- 
rated under vacuum until a volume of 5 ml was reached. 
Particle size distribution, the average size and polydisper- 
sity index were measured by laser light scattering using a 
monochromatic laser ray diffusion counter (Nanosizer N4, 
Coultronics, Margency, France). The nanoparticles had a 
monodiperse size distribution of between 170 and 200 nm. 
2.4. Cell lines and virus 
The cells used were derived from the NIH 3T3 cells 
(murine fibroblasts). Psi2neo cells [18]: they were ob- 
tained by transfection of the SVX shuttle vector (defective 
virus devoid of three viral genes: gag, pol, env). These 
cells contained these three viral genes in their genome and 
therefore allowed the budding and exit of the defective 
virus. F57 were NIH 3T3 cells chronically infected by 
Friend retrovirus. All cell lines were growing in DMEM 
medium with 5% fetal bovine serum (heated at 56°C 30 
min) and antibiotics. 
Two types of virus were used: a shuttle vector (SVX); 
this is a defective virus devoid of three viral genes (gag, 
pol, env) with the neo gene encoding for resistance to 
geneticin. The other retrovirus used was the murine Friend 
retrovirus. 
2.5. Selection of transfected cells by shuttle vectors 
The selection of the transfected cells was based on the 
geneticin resistance assay described below. Only the cells 
transfected by the defective virus and therefore containing 
the neo gene were able to grow in the presence of ge- 
neticin. NIH 3T3 cells (3.105) were plated in 60-mm Petri 
dishes and incubated at 37°C. Twenty hours after incuba- 
tion, the defective virus was added. Twenty hours follow- 
ing infection, geneticin was added at a concentration of 0.6 
mg/ml.  Six days later the resistant clones were then 
replaced to obtain an homogeneous population of NIH 3T3 
having integrated the neo gene (no virus budding occurred 
in these cells). 
2.6. Detection of antisense activity of oligonucleotides 
directed against the neo gene 
In order to evaluate the impact of virus budding on the 
efficiency of the encapsulated oligonucleotides, the neo 
gene was chosen as the target since it was present in 
psi2neo cells and in transfected NIH 3T3. Psi2neo cells 
(3.10S/plate) were incubated with oligonucleotides, free 
or encapsulated in pH-sensitive liposomes at different con- 
centrations or with empty liposomes. The anti-neo activity 
was estimated using the resistance to geneticin assay. In 
the case of these chronically transfected cells, the operat- 
ing conditions were as follows: 24 h after the addition of 
encapsulated or free oligonucleotides or empty liposomes 
to the psi2neo cells, the culture medium containing the 
defective virus was removed and used for the transfection 
of NIH 3T3 after appropriate dilution (in order to obtain 
150 clones). Selection of cells having integrated the neo 
gene was then performed: 20 h after the infection, ge- 
neticin was added at a concentration of 0.6 mg/ml.  Six 
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days later the resistant clones were stained using crystal 
violet dye and counted. We verified that the number of 
defective viruses introduced was proportional to the num- 
ber of resistant clones obtained. In a parallel experiment 
the transfected NIH 3T3 cells (3.10S/plate) were incu- 
bated with free or encapsulated oligonucleotides or empty 
liposomes, followed 24 h later, by selection with geneticin. 
2.7. Uptake of oligonucleoi~ide-liposomes 
Oligonucleotide-14C DOPE liposomes were added to 
fibroblasts (3.105/plate). The final concentration f oligo- 
nucleotides in the culture medium was 0.32 /xM and 0.3 
mM for the phospholipids. Cells were pelleted, washed 
three times in phosphate-buffered saline and the successive 
supernatants were pooled. Then the cells were lysed by 
adding water. The cell fraction was centrifuged at 10000 
x g for 5 min, leading to a pellet containing the nucleus 
and the membranes, whereas the supematant corresponded 
to the cytoplasmic fraction supematant. The three fractions 
(extracellular medium, cytoplasm and membrane pellet) 
were counted to evaluate oligonucleotide uptake and its 
association with the membrane fraction. 
2.8. Confocal microscopy 
Cells (NIH 3T3 and chronically infected I=57 cells) were 
incubated with fluorescent polystyrene nanoparticles (100 
/zl/dish) for 24 h. Confocal microscopy was then carried 
out, directly, on the cells iin the Petri dishes. The interac- 
tive confocal scanning laser microscope used was the ACA 
570 (MERIDIAN Instruments Okemos MI) with a laser 
power of 20 Mw and a neutral density filter (10% trans- 
mission). The fluorescent images were obtained with an 
excitation wavelength of 457 nm, close to the maximum 
excitation of the fluorescent polystyrene; the emission was 
observed using a band-pass filter at 500 nm. The scans 
were acquired on sections of 1 /xm of the cells. 
2.9. Fluorescence polarization studies 
The fluorescent membrane probe, 1.5 diphenyl-l.3.5- 
hexatriene (DPH), was purchased from Sigma. Two 
mmoles of DPH in tetrahydrofuran were added into 100 ml 
of PBS (pH 7.4), giving a final DPH concentration of 2 
mM [19]. A total of 10 6 NIH 3T3 or F57 cells were 
incubated with DPH for 30 min at 25°C. Then the cells 
were analysed on a FACS-440 (Becton and Dickinson, 
USA) cell sorter. The instrument analyzed the cells in 
aqueous uspension as they passed through an argon ion 
laser at 363 nm. Dead cells were excluded by light scatter 
gating measurements. The degree of fluorescence polariza- 
tion (P) was calculated by simultaneous detection of appar- 
ent fluorescence intensity in planes parallel and perpendic- 
ular, respectively, tothe polarization plane of exciting light 
[20]. The on-line computer calculated the fluorescent polar- 
ization for each cell according to the following Eq. (1): 
(I±-Iii)/(I ± +lit), where Ill and I± were the fluorescence 
intensity values recorded when fluorescent light passed 
through polarizers, oriented parallel and perpendicular, 
respectively, to the polarized excitation light. P-values 
were reflected membrane packing. The steady-state fluo- 
rescence anisotropy (r~) values were calculated from the 
P-values that could be deduced from Eq. (2). The determi- 
nation of the order parameter S was performed from r S 
using Eq. (3). These parameters do not provide informa- 
tion on membrane viscosity directly, but rather on mem- 
brane packing. 
r~ = ( Iii - I± ) / (2  Itl ÷ I± ) (2) 
[1 - 2r J0 .4  + 5( r J0 .4)2]  1/2 - 1 + rJO.4 
S = (3) 
rJO.4 
3. Results 
3.1. Inhibition of neo gene expression 
Oligonucleotide liposomes were added to psi2neo cells 
(transfected cells, which produced recombinant virus con- 
taining the neo gene) and anti-neo activity was measured 
and expressed as the percentage of inhibition of resistant 
clones growing with geniticin (Table 1). In these condi- 
tions significant inhibition of neo gene expression was 
observed which corresponded to a decrease in the produc- 
Table 1 
Inhibition of neo gene expression i cells by oligonucleotides ncapsulated in pH-sensitive liposomes 
% of inhibition of growth of genetic±n-resistant clones 
Oligonucleotide concentration (/xM) 
0.08 0.12 0.16 0.24 
Ant±sense oligo psi2neo 22 + 4 54 + 6 70 + 6 82 4- 8 
3T3 infected 7 4- 2 6 4- 1 12 4- 2 11 4- 3 
Control oligo psi2eo 4 4- 1 3 4- 1 5 4- 2 8 4- 3 
3T3 infected 5 + 2 7 ___ 1 8 _ 3 9 4- 3 
The values are expressed as the percentage of inhibition of the growth of genetic±n-resistant clones. The anti neo oligonucleotides, encapsulated in 
pH-sensitive liposomes, were added to cells containing the neo gene (3T3 and psi2neo cells). After 24 h, a selection was performed with geneticin. The 
values are expressed as the percentage of inhibition of the growth of geneticin resistant clones. The values are the mean of two experiments. 
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tion of defective viral particles containing the neo gene. 
This inhibition was measured after secondary infection of 
the recipient cells. The IC50 of liposomes with antisense 
oligonucleotides was evaluated as 0.12 /zM, whereas free 
oligonucleotides were unable to inhibit neo gene expres- 
sion up to a concentration of 25 /xM. No activity was 
detected for control oligonucleotide liposomes (Table 1). 
The addition of either oligonucleotide liposomes, or free 
oligonucleotides had no effect on neo gene expression, 
whatever the concentrations, in NIH 3T3 cells (selected to 
contain the neo gene after transfection by the defective 
virus). Empty liposomes had no effect on the inhibition of 
neo gene expression in either cell line (psi2neo and 3T3 
cells). 
3.2. Uptake of oligonucleotide liposomes by 3T3 or psi2neo 
cells 
In order to determine whether virus exiting affected the 
uptake of 14C DOPE liposomes, radioactivity was mea- 
sured in the three cell fractions (cytoplasm, the membrane 
pellet and supematant) of SVX-infected cells (NIH 3T3 
cells and of psi2neo). As shown in Table 2, the bulk of the 
radioactivity was confined to the membranes of non-in- 
fected NIH 3T3 cells. The same result (absence of uptake) 
was observed for the NIH 3T3 cells infected by the 
defective virus; it is noteworthy that the exit of the virus 
did not occur in this cell line. Only a small amount of 
radioactivity was detected in the cytoplasm. On the con- 
trary, with the psi2 neo cells, in which the exit of the virus 
occurred, a significant amount of radioactivity was found 
in the cytoplasm. It is noteworthy that although a signifi- 
cant amount of radioactivity was found in the membrane 
of all the cells after 6 h of incubation, it was only found in 
the cytoplasm of the psi2neo cells. 
Table 3 
Values of fluorescent polarisation (P), fluorescence emission anisotropy 
(r~) and order parameter (S) of Friend-infected and non-infected fibrob- 
lasts 
P r S 
Non-infected cells 0.278 _+ 0.003 0.200 + 0.003 0.648 _ 0.009 
Infected cells 0.257+0.004 0.187+0.004 0.581_+0.012 
The cells (106/plate) were incubated with a fluorescent membrane probe 
(DPH) and the suspension was analyzed on a FACS-440. The degree of 
fluorescent polarization was calculated by simultaneous detection of 
apparent fluorescence intensity in planes parallel and perpendicular to the 
polarization plane of the exciting light (the values of r and S were 
deduced from P). The data are the mean of three experiments. 
3.3. Confocal microscopy 
In order to evaluate the presence of the carrier in 
infected and non-infected fibroblasts, a study with fluores- 
cent nanoparticles was undertaken using confocal mi- 
croscopy. The cell system used was F57 cells chronically 
infected by the friend retrovirus. We have previously 
explored this system and demonstrated the efficiency of 
oligonucleotides ncapsulated in pH-sensitive liposomes. 
The violet colour in all the figures corresponds to 
background autofluorescence intensity according to the 
fluorescence scale. Fig. l a represents different sections of 
non-infected cells after incubation with fluorescent 
nanoparticles. The fluorescence was mainly located in the 
first sections, corresponding to the cell membrane (blue 
spot in section 4 to section 6); in the following sections, 
the fluorescence has disappeared. As indicated, sections 
8-9 correspond to the larger section of the cell. On the 
contrary, after incubation of the fluorescent nanoparticles 
with the infected cells, the bulk of the fluorescence was 
located in the slices corresponding to the cell interior. A 
Table 2 
Distribution kinetics of oligonucleotide t4C liposomes in transfected and non-transfected cells 
h 3T3 cells 3T3-transfected cells Psi2 neo cells 
% in cytoplasmic fraction 6 0.1 0.2 5.3 
18 0.3 0.3 7.7 
24 0.5 1.0 11.4 
36 1.1 1.5 17.5 
48 1.5 2.7 21.3 
% in the membrane pellet 6 4.5 5.7 9.3 
18 6.2 7.8 12.1 
24 8.5 11.3 14.2 
36 13.5 18.6 23.5 
48 19.8 24.2 25.4 
% non-cell-associated 6 95.4 94.1 85.4 
18 93.5 91.9 80.2 
24 91.0 87.7 74.4 
36 85.4 79.9 59.0 
48 78.7 73.1 53.3 
Cells were plated and incubated with the oligonucleotide ]4C DOPE liposomes (0.3 mM of phospholipids), the cells were lysed by adding water and the 
three fractions (medium, cytoplasm and membranes) obtained by centrifugation. Radioactivity was counted to evaluate the distribution of liposomes in the 
different fractions (n = 2). 
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C. Ropert et aL / Biochimica et Biophysica Acta 1310 (1996) 53-59 57 
la  2a 
It W B E E E I I  #~ 
| Q | | l  E t ~ $~, 
Fig. 1. (a) Uptake of the fluorescent anoparticles bynon-infected fibroblasts inconfocal microscopy at37°C. Different images of fluorescence at 1 /xm 
increments along the Z-axis of cells. Sections 9-10 correspond tothe larger section of the fibroblasts. (b) A 3-D reconstruction f 16 sections canned at 
1-/xm increments along the Z-axis of the non-infected cells labelled with fluorescent anoparticles. 
Fig. 2. (a) Uptake of the fluorescent anoparticles bychronically infected fibroblasts inconfocal microscopy at37°C. Different images of fluorescence at 
1-/xm increments along the Z-axis of cells. Sections 9-10 correspond tothe larger section of the fibroblasts. (b) A 3-D reconstruction f 16 sections 
scanned at 1-/zm increments along the Z-axis of the chronically infected cells labelled with fluorescent anoparticles. 
blue spot appeared in section 6 and fluorescence intensifi- 
cation was observed in sections 8-9-10 (Fig. 2a). When the 
fluorescent images of the individual sections were summed 
to reconstitute the fluorescence mitted by the entire cell, 
the fluorescence was found to be located in the heart of 
cell for infected cells (Fig. 2b), and limited to the cell 
membrane for non-infected cells (Fig. lb). 
3.4. Fluorescence polarization 
Fluorescent polarization of DPH-labelled cells has been 
previously shown to reflect changes induced by DMSO in 
the membrane properties of Friend leukaemic ells [19]. As 
DPH proved to be a sensitive marker for labelling fluores- 
cent polarization study, we chose to investigate the fluores- 
cence polarization (P) of infected and non-infected murine 
flbroblasts with this method in this study. As shown in 
Table 3, P-values were significantly decreased in infected 
cells, this being related to the microviscosity of the cell 
membrane. This signifies that membrane fluidity was 
greatly affected in infected cells compared to that in 
non-infected ones. 
4. Discussion 
In a previous work [16], we demonstrated the dramatic 
impact of viral infection on liposome penetration i to cells 
[16]. With a system combining the exit of defective virus 
(psi2neo cells containing gag, pol, env viral genes) and 
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cells bereft of this exit process (transfected NIH 3T3), we 
have attempted to describe the mechanism of liposome 
uptake by infected cells. In fact such a system allowed us 
to appreciate the impact of virus budding on oligonucleo- 
tide liposome uptake. Indeed, in cells allowing virus bud- 
ding (psi2neo), oligonucleotide liposomes were detected in 
the cytoplasm, whereas with transfected NIH 3T3 cells 
(devoid of an exit for viral particles) most of the radioac- 
tivity was confined to the cell membrane. These results 
provide compelling evidence that cellular uptake of lipo- 
somes is strongly correlated with virus budding. A striking 
difference was noted between the activity of encapsulated 
oligonucleotides in the two cell lines (psi2neo and 3T3). 
Clearly, the inhibition of neo gene expression by oligo- 
nucleotide liposomes was only observed in cells with a 
virus exit process. This inhibitory activity can therefore be 
correlated with uptake of oligonucleotide liposomes by 
these cells. It also suggests that oligonucleotide liposome 
efficacy is contingent on the intracellular delivery of the 
oligomers. 
In order to confirm the preferential uptake of the lipo- 
somes by infected cells allowing virus budding, the fate of 
fluorescent polystyrene nanoparticles in infected and unin- 
fected cells was investigated using confocal microscopy. 
The non-biodegradability of the polystyrene nanoparticles 
is of major interest when assessing whether fluorescence 
localization unequivocally corresponds to nanoparticles. 
This experiment revealed that, like liposomes, nanoparti- 
cles were selectively taken up by the infected cells. Thus, 
the preferential capture of colloidal carriers by infected 
cells seemed to be totally unrelated to the nature of the 
cartier (liposomes or nanoparticles) and only dependent on 
the state of the cells (infected with virus budding or not). 
The difference in the capture of liposomes or nanoparti- 
cles observed between infected and non-infected cells could 
be explained by the effect he virus exerts on the host cell 
membrane. The viral envelope is in fact composed of a 
bilayered lipid derived from the cell membrane. It is 
noteworthy that a variation in membrane fluidity of HIV 
infected cells has been observed, resulting, according to 
certain authors [21], in an increase in membrane fluidity, 
whereas others [22] have observed a decrease in membrane 
fluidity as deduced from lipid composition. 
We directly investigated membrane fluidity of the in- 
fected and uninfected fibroblasts by measuring fluores- 
cence polarization. The P-values measured (polarization 
values related to the microviscosity of the cell membranes) 
suggested that the increase in membrane fluidity was of a 
greater magnitude in infected cells. This increase probably 
reflects certain modifications in the dynamic process of the 
cell membrane triggered by virus budding which may be 
assimilated with an exocytosis process. In several cell 
systems, exocytosis is followed by the activation of 
pinocytosis [23-25]. This may result from the recapture 
and a re-use of the vesicle membrane, so that the overall 
dimensions of the cells and of the vacuolar system remain 
constant [26]. For these reasons virus budding may stimu- 
late fibroblast pinocytic activity and thus explain the in- 
creased cell capture of particulate drug carriers. 
That the virus budding is required for cell internaliza- 
tion of liposomes may prove essential for the development 
of new drug targeting strategies. However, further investi- 
gations are needed with other viruses and cells to deter- 
mine whether this is a general phenomenon or not among 
non-professional phagocytes. 
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